Log in

Neurocrine Biosciences Price Target & Analyst Ratings (NASDAQ:NBIX)

-1.04 (-0.94 %)
(As of 11/15/2019 05:27 AM ET)
Today's Range
Now: $109.87
50-Day Range
MA: $96.63
52-Week Range
Now: $109.87
Volume840,600 shs
Average Volume803,687 shs
Market Capitalization$10.12 billion
P/E Ratio499.41
Dividend YieldN/A

Analyst Ratings

Neurocrine Biosciences (NASDAQ:NBIX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
18 Wall Street analysts have issued ratings and price targets for Neurocrine Biosciences in the last 12 months. Their average twelve-month price target is $106.47, suggesting that the stock has a possible downside of 3.09%. The high price target for NBIX is $122.00 and the low price target for NBIX is $84.00. There are currently 3 hold ratings and 15 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.842.852.88
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
17 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $106.47$106.56$107.68$104.25
Price Target Upside: 3.09% downside7.63% upside13.41% upside32.93% upside

Neurocrine Biosciences (NASDAQ:NBIX) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Neurocrine Biosciences (NASDAQ:NBIX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/5/2019Canaccord GenuityBoost Price TargetBuy$120.00 ➝ $122.00Low
11/5/2019Piper Jaffray CompaniesBoost Price Target$111.00 ➝ $116.00Low
9/6/2019Royal Bank of CanadaSet Price TargetBuy$118.00Medium
7/31/2019Needham & Company LLCReiterated RatingHoldMedium
7/30/2019Credit Suisse GroupBoost Price TargetOutperform$95.00 ➝ $110.00High
7/16/2019CIBCInitiated CoverageOutperform ➝ Outperform$100.00Low
7/16/2019OppenheimerInitiated CoverageOutperform$100.00Low
7/15/2019Stifel NicolausSet Price TargetBuy$113.00Low
6/4/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$88.00Medium
4/22/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$100.00 ➝ $106.00High
4/11/2019Evercore ISIInitiated CoverageOutperformLow
3/29/2019BarclaysReiterated RatingBuy$110.00High
2/6/2019Bank of AmericaLower Price TargetBuy$124.00 ➝ $117.00Medium
2/6/2019Cantor FitzgeraldReiterated RatingOverweightHigh
1/30/2019HC WainwrightReiterated RatingBuyMedium
12/13/2018Robert W. BairdLower Price TargetOutperform$131.00 ➝ $96.00Medium
12/13/2018Leerink SwannLower Price TargetMarket Perform$110.00 ➝ $84.00Medium
12/13/2018Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$103.00Medium
11/6/2018Morgan StanleyLower Price TargetOverweight ➝ Buy$145.00 ➝ $135.00Low
9/4/2018ICAPLower Price TargetOutperform$140.00 ➝ $128.00Medium
7/30/2018Jefferies Financial GroupBoost Price TargetBuy$124.00High
5/7/2018CowenReiterated RatingBuy$100.00Low
5/1/2018Deutsche BankSet Price TargetBuy ➝ Buy$97.00 ➝ $99.00High
(Data available from 11/15/2017 forward)
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel